The seemingly higher efficacy of AZD2811NP (relative to the reported effect of sepantronium bromide) on MCC xenografts may be due to the fact that AURKB is the only enzymatic component of the CPC. This evidence concerns the gene AURKB and Merkel cell skin cancer.